Warhead biosynthesis and the origin of structural diversity in hydroxamate metalloproteinase inhibitors
- Nat Commun. 2017 Dec 6;8(1):1965. doi: 10.1038/s41467-017-01975-6.
- 1. Pharmaceutical Biology, Eberhard Karls University Tübingen, 72076, Tübingen, Germany.
- 2. German Center for Infection Research (DZIF), Partner site Tübingen, 72076, Tübingen, Germany.
- 3. Department of Molecular Microbiology, John Innes Centre, Colney Lane, Norwich, NR4 7UH, UK.
- 4. Interfaculty Institute of Microbiology and Infection Medicine, Microbiology/Biotechnology, Eberhard Karls University Tübingen, 72076, Tübingen, Germany.
- 5. Institute of Pharmaceutical Sciences, University of Freiburg, Albertstr. 25, D-79104, Freiburg i. Br., Germany.
- 6. Department of Pharmacognosy, University of Vienna, Althanstrasse 14, A-1090, Vienna, Austria.
- 7. Department of Molecular Microbiology, John Innes Centre, Colney Lane, Norwich, NR4 7UH, UK. [email protected].
- 8. Pharmaceutical Biology, Eberhard Karls University Tübingen, 72076, Tübingen, Germany. [email protected].
- 9. German Center for Infection Research (DZIF), Partner site Tübingen, 72076, Tübingen, Germany. [email protected].
Metalloproteinase inhibitors often feature hydroxamate moieties to facilitate the chelation of metal ions in the catalytic center of target Enzymes. Actinonin and matlystatins are potent metalloproteinase inhibitors that comprise rare N-hydroxy-2-pentyl-succinamic acid warheads. Here we report the identification and characterization of their biosynthetic pathways. By gene cluster comparison and a combination of precursor feeding studies, heterologous pathway expression and gene deletion experiments we are able to show that the N-hydroxy-alkyl-succinamic acid warhead is generated by an unprecedented variation of the ethylmalonyl-CoA pathway. Moreover, we present evidence that the remarkable structural diversity of matlystatin congeners originates from the activity of a decarboxylase-dehydrogenase enzyme with high similarity to Enzymes that form epoxyketones. We further exploit this mechanism to direct the biosynthesis of non-natural matlystatin derivatives. Our work paves the way for follow-up studies on these fascinating pathways and allows the identification of new Protease Inhibitors by genome mining.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
-
-